Cormorant Asset Management LP 13D and 13G filings for Longboard Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:10 pm Purchase | 2024-09-30 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Cormorant Asset Management LP | 2,790,462 8.100% | 648,956 (+30.30%) | Filing |
| 2024-02-14 3:04 pm Purchase | 2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Cormorant Asset Management LP | 2,141,506 9.990% | 339,559 (+18.84%) | Filing |
| 2023-02-14 3:05 pm Purchase | 2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Cormorant Asset Management LP | 1,801,947 9.990% | 420,015 (+30.39%) | Filing |
| 2022-02-14 3:16 pm Purchase | 2021-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Cormorant Asset Management LP | 1,381,932 9.990% | 42,301 (+3.16%) | Filing |
| 2021-03-26 4:05 pm Purchase | 2021-03-16 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Cormorant Asset Management LP | 1,339,631 9.990% | 1,339,631 (New Position) | Filing |